SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-20-000013
Filing Date
2020-02-10
Accepted
2020-02-10 16:56:31
Documents
1
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158137177371826.html 4  
1 FORM 4 wf-form4_158137177371826.xml 4 3744
  Complete submission text file 0000899866-20-000013.txt   5207
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address
Bazarko Daniel (Reporting) CIK: 0001768214 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 20592719